alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
M A N D A T E

TO THE 93RD DISTRICT COURT of HIDALGO COUNTY, GREETINGS:

Before our Court of Appeals for the Thirteenth District of Texas, on the 20th day of

November, 2014, the cause upon appeal to revise or reverse your judgment between

Martina D. Rodriguez, Appellant,

v.

Luis Antonio Pimentel and Petronila

M. Pimentel

Appellees.

CAUSE NO. 13-14-00273-CV (Tr.Ct.No. C-2785-07-B)

was determined; and therein our said Court made its order in these words:

THE THIRTEENTH COURT OF APPEALS, having considered this cause on

appeal, concludes the judgment of the trial court should be reversed and the cause

remanded to the trial court. The Court orders the judgment of the trial court

REVERSED and REMANDED for further proceedings consistent with its opinion. Costs

of the appeal are adjudged against appellees.

We further order this decision certified below for observance.

      

WHEREFORE, WE COMMAND YOU to observe the order of our said Court of Appeals

for the Thirteenth District of Texas, in this behalf, and in all things have it duly

recognized, obeyed and executed.

WITNESS, the Hon. Rogelio Valdez, Chief Justice of our Court of Appeals, with the seal

thereof affixed, at the City of Edinburg, Texas this 18th day of May, 2015.

Dorian E. Ramirez, CLERK

FILE COPY
Editorial Note on Part 878
Editorial Note: Nomenclature changes to part 878 appear at 73 FR 35341, June 23, 2008.

§ 878.3540 Silicone gel-filled breast prosthesis. ( a ) *Identification* — ( 1 ) *Single-lumen silicone gel-filled breast prosthesis.* A single-lumen silicone gel-filled breast prosthesis is a silicone rubber shell made of polysiloxane(s), such as polydimethylsiloxane and polydiphenylsiloxane. The shell either contains a fixed amount cross-linked polymerized silicone gel, filler, and stabilizers or is filled to the desired size with injectable silicone gel at time of implantation. The device is intended to be implanted to augment or reconstruct the female breast.
( 2 ) *Double-lumen silicone gel-filled breast prosthesis.* A double lumen silicone gel-filled breast prosthesis is a silicone rubber inner shell and a silicone rubber outer shell, both shells made of polysiloxane(s), such as polydimethylsiloxane and polydiphenylsiloxane. The inner shell contains fixed amounts of cross-linked polymerized silicone gel, fillers, and stabilizers. The outer shell is inflated to the desired size with sterile isotonic saline before or after implantation. The device is intended to be implanted to augment or reconstruct the female breast.
( 3 ) *Polyurethane covered silicone gel-filled breast prosthesis.* A polyurethane covered silicone gel-filled breast prosthesis is an inner silicone rubber shell made of polysiloxane(s), such as polydimethylsiloxane and polydiphenylsiloxane, with an outer silicone adhesive layer and an outer covering of polyurethane; contained within the inner shell is a fixed amount of cross-linked polymerized silicone gel, fillers, and stabilizers and an inert support structure compartmentalizing the silicone gel. The device is intended to be implanted to augment or reconstruct the female breast.
( b ) *Classification.* Class III.
( c ) *Date premarket approval application (PMA) is required.* A PMA is required to be filed with the Food and Drug Administration on or before July 9, 1991 for any silicone gel-filled breast prosthesis that was in commercial distribution before May 28, 1976, or that has on or before July 9, 1991 been found to be substantially equivalent to a silicone gel-filled breast prosthesis that was in commercial distribution before May 28, 1976. Any other silicone gel-filled breast prosthesis shall have an approved PMA in effect before being placed in commercial distribution.
[53 FR 23872, June 24, 1988, as amended at 56 FR 14627, Apr. 10, 1991]
# C_2014261EN.01004301.xml

| 11.8.2014 | EN | Official Journal of the European Union | C 261/43 |
| --- | --- | --- | --- |

11.8.2014

EN

Official Journal of the European Union

C 261/43

---

Action brought on 16 June 2014 — TAO/AFI and SFIE v Parliament and Council

(Case T-456/14)

2014/C 261/69

Language of the case: French

Parties

Parties

Applicants: Association des Fonctionnaires Indépendants pour la Défense de la Fonction Publique Européenne/Association of Independent Officials for the Defence of the European Civil Service (TAO/AFI) (Brussels, Belgium) and Syndicat des Fonctionnaires Internationaux et Européens/Union of International and European Civil Servants (SFIE) (Brussels, Belgium) (represented by: M. Casado García-Hirschfeld, lawyer)

Applicants:

Defendants: Council of the European Union and European Parliament

Defendants:

Form of order sought

Form of order sought

The applicants claim that the Court should:

| — | Declare the present action for annulment before it admissible; |
| --- | --- |

—

Declare the present action for annulment before it admissible;

| — | Annul the contested Regulations with all the attendant consequences in law; |
| --- | --- |

—

Annul the contested Regulations with all the attendant consequences in law;

| — | Order the defendants to pay the costs in their entirety. |
| --- | --- |

—

Order the defendants to pay the costs in their entirety.

Pleas in law and main arguments

Pleas in law and main arguments

In support of the action, the applicants rely on a single plea in law alleging infringement of the prerogatives which they have as trade unions and professional associations, namely the right to consultation and the right of negotiation.

The applicants were not consulted either at the stage of preparation of the proposals or during the stage of the negotiations in respect of the disputed Regulations.

---
## COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NO. 02

- 13

- 00064

- CV

Jonathan Aflatouni, a/k/a John

Aflatouni

v.

Mark Anthony Montoya and Enid

Montoya §

§

§

§

§ From the 431st District Court

of Denton County

(2012

- 71252

- 431)

April 30, 2015

Opinion by Justice Dauphinot



### JUDGMENT

This court has considered the record on appeal in this case and holds that

there was no error in the trial court’s order . It is ordered that the order of the trial

court is affirmed. We remand this case to the trial court for further proceedings.

It is further ordered that Appellant Jonathan Aflatouni, a/k/a John Aflatouni

shall pay all of the costs of this appeal, for which let execution issue.

SECOND DISTRICT COURT OF APPEALS

By

__ /s/ Lee Ann Dauphinot

_____________ Justice Lee Ann Dauphinot
Editorial Note on Part 886
Editorial Note: Nomenclature changes to part 886 appear at 73 FR 35341, June 23, 2008.

§ 886.4390 Ophthalmic laser. ( a ) *Identification.* An ophthalmic laser is an AC-powered device intended to coagulate or cut tissue of the eye, orbit, or surrounding skin by a laser beam.
( b ) *Classification.* Class II.
§ 582.6290 Disodium phosphate. ( a ) *Product.* Disodium phosphate.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
- USGS Home
- Contact						   USGS
- Search 
USGS

- mobile menu barsUSGS Publications Warehouse
    Contact
    Explore recent publications 
    by USGS							   Authors
    Browse all of Pubs Warehouse 
    by							   Publication type and year
    FAQS
    Web 
    Service Documentation
    Other 
    Resources
    Descriptions of US 
    Geological Survey Report							   Series
- USGS Publications Warehouse
- Contact
- Explore recent publications 
    by USGS							   Authors
- Browse all of Pubs Warehouse 
    by							   Publication type and year
- FAQS
- Web 
    Service Documentation
- Other 
    Resources
- Descriptions of US 
    Geological Survey Report							   Series

- USGS Publications 
  Warehouse
- Explore					    
  Explore recent publications 
    by USGS							   Authors
    Browse all of Pubs Warehouse 
    by							   Publication type and year
- Explore recent publications 
    by USGS							   Authors
- Browse all of Pubs Warehouse 
    by							   Publication type and year
- Documentation					    
  FAQS
    Web 
    Service Documentation
    Other 
    Resources
    Descriptions of US 
    Geological Survey Report							   Series
- FAQS
- Web 
    Service Documentation
- Other 
    Resources
- Descriptions of US 
    Geological Survey Report							   Series
- Contact

### The gold quartz veins of Grass Valley, California

#### Professional Paper 194

Tweet


#### Links

- Document: **Document**
- Plates:
- **Plate 1**                                
    (pdf)
- **Plate 2**                                
    (pdf)
- **Plate 27**                                
    (pdf)
- **Plate 32**                                
    (pdf)
- **Plate 35**                                
    (pdf)
- Download citation as:  RIS

#### Abstract

#### Study Area



#### Additional publication details

Part or all of this report is presented in Portable 
Document Format (PDF). For best results viewing and printing PDF documents, it 
is recommended that you download the documents to your computer and open them 
with Adobe Reader. PDF documents opened from your browser may not display or 
print as intended. Download the latest version of Adobe 
Reader, free of charge. More information about viewing, downloading, and 
printing report files can be found here.

Accessibility
				    FOIA				    Privacy				    Policies and					   
Notices

U.S. Department of the					   Interior |				    
U.S. Geological 
Survey				   URL: http://pubs.er.usgs.gov/publication/pp194 
                    				   Page Contact Information: Pubs 
Warehouse Contact				   Page				   Page Last Modified: June 26, 2013 
16:04:43
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.1645 Aluminum powder. ( a ) *Identity.* ( 1 ) The color additive aluminum powder shall be composed of finely divided particles of aluminum prepared from virgin aluminum. It is free from admixture with other substances.
( 2 ) Color additive mixtures for external drug use made with aluminum powder may contain only those diluents listed in this subpart as safe and suitable in color additive mixtures for coloring externally applied drugs.
( b ) *Specifications.* Aluminum powder shall conform to the following specifications and shall be free from impurities other than those named to the extent that such impurities may be avoided by good manufacturing practice: Fineness, 100 percent shall pass through a 200-mesh screen and 95 percent shall pass through a 325-mesh screen. Mercury, not more than 1 part per million. Arsenic, not more than 3 parts per million. Lead, not more than 20 parts per million. Aluminum, not less than 99 percent.
( c ) *Uses and restrictions.* Aluminum powder is safe for use in externally applied drugs, including those intended for use in the area of the eye, in amounts consistent with good manufacturing practice.
( d ) *Labeling.* The color additive and any mixture prepared therefrom intended solely or in part for coloring purposes shall bear, in addition to any information required by law, labeling in accordance with § 70.25 of this chapter.
( e ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore batches therof are exempt from certification pursuant to section 721(c) of the act.
[42 FR 38563, July 29, 1977]
Editorial Note on Part 892
Editorial Note: Nomenclature changes to part 892 appear at 73 FR 35341, June 23, 2008.

§ 892.1640 Radiographic film marking system. ( a ) *Identification.* A radiographic film marking system is a device intended for medical purposes to add identification and other information onto radiographic film by means of exposure to visible light.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 892.9.
[55 FR 48444, Nov. 20, 1990, as amended at 59 FR 63015, Dec. 7, 1994; 66 FR 38819, July 25, 2001]
#### § 820.60 Identification.

Each manufacturer shall establish and maintain procedures for identifying product during all stages of receipt, production, distribution, and installation to prevent mixups.
<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0000814576
<NAME>                        PAINEWEBBER R&D PARTNERS II, L.P.

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-END>                                   SEP-30-2000
<CASH>                                         6,998
<SECURITIES>                                   2,304,298
<RECEIVABLES>                                  1,435,000
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               3,746,296
<PP&E>                                         0
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 3,746,296
<CURRENT-LIABILITIES>                          418,578
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     3,327,718
<TOTAL-LIABILITY-AND-EQUITY>                   3,746,296
<SALES>                                        0
<TOTAL-REVENUES>                               12,013,995
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               705,852
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                11,308,143
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   11,308,143
<EPS-BASIC>                                    0
<EPS-DILUTED>                                  0



</TABLE>
Editorial Note on Part 878
Editorial Note: Nomenclature changes to part 878 appear at 73 FR 35341, June 23, 2008.

§ 878.4340 Contact cooling system for aesthetic use. ( a ) *Identification.* A contact cooling system for aesthetic use is a device that is a combination of a cooling pad associated with a vacuum or mechanical massager intended for the disruption of adipocyte cells intended for non-invasive aesthetic use.
( b ) *Classification.* Class II (special controls). The special controls for this device is FDA's “Guidance for Industry and FDA Staff; Class II Special Controls Guidance Document: Contact Cooling System for Aesthetic Use.” See § 878.1(e) for the availability of this guidance document.
[76 FR 6553, Feb. 7, 2011]
T hi s di s pos i t i on i s notappr opr i a t e f orpubl i c a t i on and i s notpr e c e de nt * e xc e pta s pr ovi de d by 9th C i r . R . 36- 3.

T he pa ne l una ni m ous l yc onc l ude s thi s c a s e i s s ui t abl e f orde c i s i on ** w ith o u t o r a l a r g u m e n t. See F ed. R . A pp . P . 34 (a )( 2). NOT F OR P UB L I CAT I ON UN I TE D STATE S C OU RT OF APPE ALS FOR T HE NI NTH CI RC UI T UN I T E D S T AT E S OF AME R I C A, P l ai nt i ff

- A pp el l ee , v. B R AN DO N P AT R I C K A KA NA , D e f

e n d a n t - A p p e lla n t. N o. 12- 10602 D. C . No . 1 : 9 7 - c r - 0 0 6 8 7 - DA E ME MOR AN DU M *

A pp ea l fr om the U ni t ed S t at es D i stri ctC ou rt

f o rth e D is tr ic t o f

H a w a ii D a vi d A . E z r a , D i s tr i c tJ udge , P r e s i di ng S ubm i tt e d J une 10, 2013 ** B efo re: H A W K IN S , M cK E O W N , an d B E R Z O N , C i rcu i tJu d g es. B r a ndon P a tr i c k A ka naappe a l s f r om the di s tr i c tc ourt ’ s j udgm e nta nd c h a lle n g e s th e 2 2 - m o n th s e n te n c e im p o s e d u p o n r e v o c a tio n o f s u p e rv is e d r e le a s e . W e h a v e j u r i s d i c t i o n u n d e r2 8 U . S. C. § 1 2 9 1 , a n d w e a f f i rm. A ka nac ont e nds tha tthe di s tr i c tc ourte rr e d byi m pe rm i s s i bl yl e ngthe ni ng 

# FI LED JU N 13 2013 M OLLY C. DW Y ER, CLERK U . S. C O U R T OF APPE ALS12- 10602 2 h is s e n te n c e b a s e d o n th e n e e d f o rr e h ab ilita tio n . W e r e v ie w f o rp la in e rr o r , se e U ni te d State s v . G r ant , 664 F . 3d 276, 279 ( 9th C i r . 2011) , a nd f i nd none . T hough the di s tr i c tc ourtdi s c us s e d r e habi l i t a t i on dur i ng the s e nt e nc i ng he a r i ng, i tdi d not im p o s e o rle n g th e n th e s e n te n c e b a s e d o n A k a n a ’s r e h ab ilita tiv e n e e d s . See T a p ia v. U ni ted Stat es , 131 S . C t . 2382, 2392 ( 2011) ( “ A c ourtc om m i t s no e rr orby di s c us s i ng the opportuni t i e s f orr e habi l i t a t i on w i thi n pr i s on orthe be ne f i t s of spec i fi c tre atm entor tra i ni ng prog ra m s. ”) . W e d e c lin e to r e a c h A k a n a ’s a r g u m e n t th a t th e d is tr ic t c o u rt im p r o p e r ly r e l i e d on the ne e d f

orpuni s hm e nti n i m pos i ng s e nt e nc e be c aus e i ti s r a i s e d f orthe f ir s t tim e in th e r e p lyb r ie f . Se e Un i te d

S ta te s v . R o mm , 4 5 5 F .3 d 9 9 0 , 9 9 7 ( 9 th C i r. 20 06 ). A ka na ’ s m ot i on f

orr e c ons i de r a t i on of

the c ourt ’ s or de rgr a nt i ng the g o v e rn m e n t’s r e q u e s t to e x te n d tim e to f ile th e a n s w e r in g b r ie f

is d e n ie d a s m o o t. AF F I RME D.
Opinion issued January 28, 2014

In The

Court of Appeals 

For The 

First District of Texas 

————————————

NO. 01-13-00926-CV

———————————

ELIJAH SMITH, Appellant

V.

BIG BASS RESORT, Appellee

On Appeal from the County Civil Court at Law No. 2

Harris County, Texas

Trial Court Case No. 1037700

MEMORANDUM OPINION

Appellant, Elijah Smith, has neither paid the required fees nor established 

indigence for purposes of appellate costs. See TEX. R. APP. P. 5, 20.1; see also

TEX. GOV’T CODE ANN. §§ 51.207, 51.941(a), 101.041 (West 2013); Order 

Regarding Fees Charged in Civil Cases in the Supreme Court and the Courts of 
2

Appeals and Before the Judicial Panel on Multidistrict Litigation, Misc. Docket 

No. 07-9138 (Tex. Aug. 28, 2007), reprinted in TEX. R. APP. P. app. A § B(1). 

After being notified that this appeal was subject to dismissal, appellant did not

adequately respond. See TEX. R. APP. P. 5, 42.3(c).

Accordingly, we dismiss the appeal for nonpayment of all required fees. We 

dismiss all other pending motions as moot.

PER CURIAM

Panel consists of Justices Keyes, Bland, and Brown.
§ 876.4620 Ureteral stent. ( a ) *Identification.* A ureteral stent is a tube-like implanted device that is inserted into the ureter to provide ureteral rigidity and allow the passage of urine. The device may have finger-like protrusions or hooked ends to keep the tube in place. It is used in the treatment of ureteral injuries and ureteral obstruction.
( b ) *Classification.* Class II (performance standards).
# C_2015389EN.01005102.xml

| 23.11.2015 | EN | Official Journal of the European Union | C 389/51 |
| --- | --- | --- | --- |

23.11.2015

EN

Official Journal of the European Union

C 389/51

---

Judgment of the General Court of 30 September 2015 — Volkswagen v OHIM (ULTIMATE)

(Case T-385/14) (1)

1

((Community trade mark - Application for Community word ULTIMATE - Absolute ground for refusal - Absence of distinctive character - Article 7(1)(b) of Regulation (EC) No 207/2009))

(2015/C 389/57)

Language of the case: German

Parties

Parties

Applicant: Volkswagen AG (Wolfsburg, Germany) (represented by: U. Sander, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: D. Walicka, acting as Agent)

Defendant:

Re:

Re:

Action brought against the decision of the First Board of Appeal of OHIM of 24 March 2014 (Case R 1787/2013-1), concerning an application for registration of the word sign ULTIMATE as a Community trade mark.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1) | Dismisses the action; |
| --- | --- |

1)

Dismisses the action;

| 2) | Orders Volkswagen AG to bear its own costs and to pay those incurred by the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM). |
| --- | --- |

2)

Orders Volkswagen AG to bear its own costs and to pay those incurred by the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM).

---

(1)  OJ C 253, 4.8.2014.

1

---
EXHIBIT
32.2


SECTION
1350 CERTIFICATION





I,
Edward P. Smolyansky, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the
Quarterly Report of Lifeway Foods, Inc. (the “Company”) on Form 10-QSB for nine
month period ended March 31, 2008:





(1)
Fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and





(2)
that the information contained in the report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.





This
written statement is being furnished to the Securities and Exchange Commission
as an exhibit to such Form 10-QSB. A signed original of this written statement
required by Section 906 has been provided to the Company and will be
retained by the Company and furnished to the Securities and Exchange Commission
or its staff upon request.





Date:
      May 15, 2008
            /s/
      Edward P. SmolyanskyChief
      Financial and Accounting Officerand
      Treasurer
§ 884.1185 Endometrial washer. ( a ) *Identification.* An endometrial washer is a device used to remove materials from the endometrium (the mucosal lining of the uterus) by washing with water or saline solution and then aspirating with negative pressure. This device is used to study endometrial cytology (cells).
( b ) *Classification.* Class II. The special controls for this device are: ( 1 ) FDA's: ( i ) “Use of International Organization for Standardization's ISO 10993 ‘Biological Evaluation of Medical Devices—Part I: Evaluation and Testing,’ ” and
( ii ) “510(k) Sterility Review Guidance of 2/12/90 (K90-1),”
( 2 ) Labeling: ( i ) Indication: Only to evaluate the endometrium,
( ii ) Contraindications: Pregnancy, history of uterine perforation, or a recent cesarean section, and
( iii ) Warning: Do not attach to a wall or any external suction, and
( 3 ) Design and Testing: ( i ) The sampling component is covered within the vagina, and
( ii ) Intrauterine pressure should not exceed 50 millimeters of mercury.
[45 FR 12684, Feb. 26, 1980, as amended at 52 FR 17741, May 11, 1987; 65 FR 17146, Mar. 31, 2000]
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.2100 Cardiovascular blood flowmeter. ( a ) *Identification.* A cardiovascular blood flowmeter is a device that is connected to a flow transducer that energizes the transducer and processes and displays the blood flow signal.
( b ) *Classification.* Class II (performance standards).
* Pursuant to 5TH CIR. R. 47.5, the court has determined that

this opinion should not be published and is not precedent except

under the limited circumstances set forth in 5TH CIR. R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 00-60699

 

HAROLD W. KAHLA; JULIA A. KAHLA,

Petitioners-Appellants,

versus

COMMISSIONER OF INTERNAL REVENUE,

Respondent-Appellee.

 

Appeal from the Decision of the

United States Tax Court

(12318-97)

 

September 7, 2001

Before HIGGINBOTHAM, BARKSDALE, and STEWART, Circuit Judges.

PER CURIAM:*

We affirm for essentially the reasons stated by the Tax Court.

AFFIRMED.